Medication info
Tenelia M Sustained-release Tablet 10/500 mg

Tenelia M Sustained-release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletTeneligliptin Hydrobromide Hydrate›15.5mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Orange egg-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201501699 · Approved 2015.03.31 · Insurance code 652105460

Summary

Main use
Improvement of blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, dose reduction of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Since such a change may result in changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes

View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It particularly helps to manage blood sugar levels more effectively by administering Teneligliptin and Metformin together. Taking this medication stabilizes blood sugar levels, significantly aiding in the management of diabetes. It supports patients in reducing blood sugar fluctuations in daily life. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, dose reduction of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Since such a change may result in changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.

Precautions

This medication aids in controlling blood sugar, but a rare side effect known as severe lactic acidosis may occur in some patients. This side effect can be particularly risky for those with impaired kidney function or those with heart disease, sepsis, etc. This medication should not be given to patients with moderate to severe impairment of kidney function, heart failure, acute myocardial infarction, or sepsis. Additionally, the use of this medication should be temporarily suspended before and after examinations using iodinated contrast agents, and patients with liver dysfunction or pregnant women should avoid its use. When used in conjunction with other medications for diabetes treatment, the risk of hypoglycemia may increase, so patients should be well-informed about the symptoms of hypoglycemia and may need to adjust dosages of other medications as necessary. During treatment, kidney function and liver function should be regularly monitored to ensure there are no abnormalities, and vitamin B12 levels may decrease, so monitoring is advisable. During this medication, dehydration, severe vomiting or diarrhea, acute infections, and before and after surgery should lead to temporary discontinuation of its use, and if sudden abdominal pain or vomiting occurs, which may suggest pancreatitis, immediate consultation with healthcare professionals is necessary. Alcohol consumption may increase the risk of lactic acidosis, so it is important not to overindulge during treatment. Particularly, caution is needed for the elderly or those with reduced kidney function, and patients and families should be adequately informed of symptoms of hypoglycemia or lactic acidosis that may occur with this medication. Finally, this medication has not established safety and efficacy in children, so it is advisable not to use it.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
Show 192 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • increased serum potassium concentration
  • lethargy
  • allergic rhinitis
  • increased serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood glucose
  • elevated blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • spinal disc herniation
  • spinal disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urolithiasis
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • paresthesia
  • muscular weakness
  • back pain
  • limb pain
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformities
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • cough
  • insomnia
  • urticaria
  • hepatic coma
  • sensory impairment
  • sensory reduction
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • position-related dizziness
  • headache
  • herpes zoster
  • gastroenteritis
  • H1N1 influenza
  • bronchitis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • athlete's foot
  • subcutaneous abscess
  • Helicobacter gastritis
  • gastritis
  • dyspepsia
  • vomiting
  • upper abdominal pain
  • abdominal pain
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • hypercholesterolemia
  • hyperglycemia
  • falls
  • animal bites
  • radial fracture
  • chronic bronchitis
  • nasal obstruction hypertrophy
  • atherosclerosis
  • hypertension
  • hearing loss
  • endolymphatic hydrops
  • vertigo
  • increased blood creatinine
  • elevated blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina pectoris
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy
  • breast cancer
  • uterine abscess
  • headache
  • musculoskeletal chest pain
  • arthralgia
  • spinal disc degeneration

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius to preserve the medication's effectiveness for a long time.

Appearance and packaging

Appearance

Orange egg-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.